http://www.incirculation.net/NewsIt...I-patients-with-diabetes-.aspx?usechannel=DIA
Sulfonylurea CV risk in MI patients.... "Several, but not all, sulfonylureas are associated with increased cardiovascular risk compared with metformin therapy in patients with diabetes who do not undergo emergent percutaneous coronary intervention (PCI) after myocardial infarction (MI), research suggests."
Sulfonylurea CV risk in MI patients.... "Several, but not all, sulfonylureas are associated with increased cardiovascular risk compared with metformin therapy in patients with diabetes who do not undergo emergent percutaneous coronary intervention (PCI) after myocardial infarction (MI), research suggests."
